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Abstract 
This project targeted gene expression in specific brain regions known to play a 
role in autism spectrum disorders (ASD).  Due to ASD affecting males four times more 
often than females, we compared the male and female gene expression in different brain 
regions.  Specific brain regions were extracted and analyzed using a PCR panel 
containing 84 neurotransmitter genes to identify differences between males and females 
in gene expression.  Gabrb3 was found to be significantly higher in females than males.  
siRNA gene silencing was tested in the second part of the project for studying 
functionality.  In the trial, the injection of gene specific siRNA, Mapk1, was shown to 
completely silence expression of the targeted gene.  This would be the next step in 
identifying which genes are specific to autism. 
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 1 Introduction 
Autism spectrum disorders (ASD) are neurodevelopment disorders that are 
characterized by impaired social interaction, deficits in communication, and repetitive 
behaviors and restricted interests.  One out of 166 newborns is affected by ASD, likely 
caused by both genes and environment.  Parents are usually the first to notice a problem 
with the child, usually noticing that the child is unresponsive to people and/or focusing 
on one thing intently for an extended period of time (National Institute of Mental Health).  
The developmental disorders can range from mild to severe.  There is no single best 
treatment plan for all affected children.  Early intervention is vital since individuals 
respond to highly specialized programs.   
Genetic factors are known to play a role in the etiology, as indicated by the 
difference in concordant rates for ASD between identical twin (ranging from 36% to 
96%) and dizygotic twin (0%).  The focus has been brought to specific chromosomal 
regions that possibly contain autism-related genes (National Alliance for Autism 
Research).  These “autism susceptible genes” make certain individuals more vulnerable 
by influencing their brain development and/or function.  One such gene is Gabrb3 which 
has an important role in neuronal 
communication (see below).   
In neuropathologic examinations, 
anatomical changes have been consistently 
found in autism patients in the cerebellum, 
cerebral cortex, and limbic system.  Based on 
recent technologies, scientists have been able 
to study the structure and function of specific 
brain regions.  Some of these technologies 
include positron tomography (PET), 
computerized tomography (CT) and 
magnetic resonance imaging (MRI).  Using these new advances, major brain structures 
associated with autism have been found, including the cerebellum, cerebral cortex, corpus 
Figure 1: Location of amygdala. 
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callosum, brain stem, hippocampus, and the limbic system (National Institute of Mental 
Health).   
One important component of the limbic system is the amygdala, which was chosen 
as the focus of our initial analysis.  The amygdala plays an important role in appraising 
emotionally relevant information in social interaction.  It is also responsible for emotional 
responses, including aggressive behavior (National Institute of Mental Health).  Altered 
neural activities in the amygdala were revealed by fMRI and PET scans in people with 
ASD while they were engaged in social perception tasks.  In the amygdala, GABAergic 
neurons play an essential role in emotion perception and memory formation.  Specifically 
GABA-A receptor genes including Gabrb3 have been identified as autism loci in genome 
scans.   
GABAA receptors are important for proliferation, migration, and differentiation of 
precursor cells that coordinate development of the embryonic brain.  GABAA receptors 
consist of eight different types of subunits: α1-6, β1-4, γ1-3, δ, ρ1-2, π, ε, and θ. Protein 
subunits co-assemble with other protein molecules to form an oligomeric protein. 
Amongst GABA subunit genes, there is a cluster consisting of Gabrb3, Gabra5, and 
Gabrg3.  Together, the proteins coded by this gene cluster have unique regional and 
distribution in the central nervous system.  Gabrb3 is vital for both mature brain function 
and correct brain development (DeLorey, 208).  Based on a study by DeLorey, et. al., it 
has been found that gabrb3-/- mice exhibit social deficits in behavior, similar to that of 
ASD.  This leads us to believe that the gene Gabrb3 has a part to play in the development 
of ASD. 
Boys are four times more likely to be diagnosed with ASD than girls.  The 
underlying biological mechanism is unclear.  One possibility is that gene expression, and 
in turn neuronal activity differs between the two sexes in autism-related brain regions 
such as the amygdala.  Mice and humans show similar gene expression patterns in the 
brain and therefore we performed gene expression analysis in the amygdala between 
adult male and female mice.   
Once a gene is found to be expressed differently between males and females, its 
involvement in amygdala function as well as social behavior can be further analyzed by 
RNA interference method, which allows brain-region specific gene silencing.   
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RNA interference, or RNAi, is a 
mechanism for RNA guided regulation 
of gene expression where double 
stranded RNA (dsRNA) inhibits the 
expression of genes with 
complementary nucleotide sequences.   
The pathway can be seen in Figure 2.  
The RNAi pathway is initiated by 
dicer, an enzyme that cleaves dsRNA 
to short fragments about 20-25 base-
pairs in length.  The guide strand is 
incorporated into the RNA-induced 
silencing complex, or RISC, where it 
base-pairs with its complementary 
sequence. 
 The most well known outcome of this is post-transcriptional RNA gene silencing.  
This occurs when the guide strand base-pairs with mRNA to induce degradation of the 
mRNA by the catalytic component of the RISC complex.  The results of this are short 
RNA fragments and are commonly known as small interfering RNA (siRNA) or 
microRNA (miRNA).  The difference between siRNA and miRNA are dependant upon 
whether the fragments are from exogenous sources, siRNA, or when they are produced 
endogenously from RNA-coding genes, miRNA.  
  
Figure 2: RNAi pathway. The enzyme dicer trims double 
stranded RNA, to form small interfering RNA or 
microRNA. These processed RNAs are incorporated into 
the RNA-induced silencing complex (RISC), which 
targets messenger RNA to prevent translation 
(Hammond, S) 
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2 Materials and Methods 
2.1 Mouse Model 
The animals used in this study were two month old adult black 6 mice.  The brain 
was freshly dissected from a two month old mouse and then frozen.  The frozen brain 
was then placed in the cryostat and a 1 mm micropunch was used to isolate specific brain 
regions such as amygdala. 
2.2 RNA Samples 
An RNA extraction was performed using 
Qiagen’s RNAeasy Mini Kit to isolate the RNA 
(Qiagen, Valencia, CA).  The protocol followed 
was the one detailed in the manual found on the 
Qiagen website, 
(http://www1.qiagen.com/literature/handbooks/l
iterature.aspx?id=1000291).  The total RNA 
obtained was then run in the spectrophotometer 
to measure the concentration of the RNA.  A 
1.5% agarose gel was also run at 90 volts to 
assess the quality of the RNA.  The quality of 
the RNA was confirmed by the presence of two bands, 18S and 28S bands which can be 
seen in Figure 3. 
Figure 3: RNA integrity can be viewed by 
gel electrophoresis 
2.3 SuperArray Analysis 
Neurotransmitter Receptor SuperArrays (SuperArray, Frederick, MD) were used 
which are 96-well plates allowing simultaneous measurements of 84 genes on a real time 
PCR machine.  The protocol followed was the one that was detailed in the manual online, 
(http://www.superarray.com/Manual/pcrarrayplate.pdf).  These genes encode receptors 
for neurotransmitters such as acetyl-choline, dopamine, and GABA.  Four pooled 
samples, 2 male and 2 female samples, were tested.  Each sample contained amygdala 
RNA derived from 3 mice. 
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G11  
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G12  
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H02  
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H03  
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H04  
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H05  
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H06  
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H07  
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H08  
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H10  
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Table 1:  Gene Table of Mouse Neurotransmitter Receptors and Regulators 
A detailed list of the genes can be found in Appendix A on page 24 of this document. 
Expression of these genes was shown based on comparative expression of Gapdh 
expression.  These results were calculated using the following calculations. 
The relative expression of each gene was calculated using the formula:  
ΔCt = CtGOI – Ct AVG(HKG) 
Where CtGOI is the Ct value of gene of interest determined on the real time PCR 
machine indicating abundance of specific mRNA and CtAVG(HKG) is the average Ct 
value of five housekeeping genes. 
The relative expression (Exp) of each gene was calculated using the formula,  
Exp = 2-ΔCt (ΔCt = CtGOI – CtGapdh) 
To determine statistical significance (p < .05)  t-tests were used to compare males and 
females.  Six samples were included for each sex. 
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The SuperArray kit simultaneously measures 84 genes in a 96 well plate.  The 
remaining 12 wells contain a combination of controls.  Wells H1-H5 contain the 
housekeeping genes.  These genes are control genes that should definitely show 
expression.  These genes include:  Gusb, Hsprt1, Hsp90ab1, Gapdh, and Actb.  The 
housekeeping genes are used to normalize expression in the other 84 genes. 
Another important gene of the control genes is the MGDC, or mouse genomic 
DNA contamination.  It can be found in well H6.  Since there is no purification method 
that can guarantee that RNA is completely DNA free, it is vital to know if there is any 
residual DNA that is still present with the RNA.  The MGDC tests specifically for 
genomic DNA contamination in each sample.  A MGDC threshold cycle less than 30 
indicates a significant presence of genomic DNA contamination. 
2.4 Individual Gene Analysis 
2.4.1 cDNA Synthesis 
Complementary DNA (cDNA) was synthesized from RNA.  When synthesizing 
cDNA, it is necessary to remove any DNA contaminants.  This was done with a genomic 
DNA elimination step.  In order to make DNA-free RNA, a kit by Ambion (Austin, TX) 
was used.  The protocol followed was the one given by the company 
(http://www.ambion.com/techlib/prot/bp_1906.pdf). 
Using the DNA free RNA, cDNA was synthesized using Invitrogen’s SuperScript 
III Platinum Two-Step qRT-PCR Kit (Invitrogen, Valencia, CA).  The protocol followed 
was the one detailed in the manual.  The cDNA synthesized was later used to test specific 
gene primers to identify any sex differences using real-time PCR. 
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2.4.2 Real-time PCR 
cDNA was synthesized with reverse transcriptase (Invitrogen) followed by real 
time PCR quantifications using gene-specific primers.  Primer sequences were obtained 
from the PrimerBank website and primers were ordered from IDT (Coralville, IA). 
 
Figure 4: Graph showing linearity of serial dilution. 
  Each primer pair was tested for linearity with serial diluted samples and 
specificity which was indicated by aligned disassociation curves across samples.  Gapdh 
expression was also quantified serving as a reference for loading. 
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Figure 5:  Graph showing dissociation curve 
2.5 siRNA Injection 
Gene specific siRNA was purchased from Qiagen and mixed with DOTAP (Roche, 
Penzberg, Germany) which served as transfection vector.  Each injection of 3.75μg 
siRNA in 1μl was delivered with a Precision pump into the brain of adult BL6 mice.  
Brain region specific expression of the target gene was analyzed two days after the 
injection. 
2.6 Cell Culture 
P19 stem cells were used for the cell cultures.  Three different plates were used, 
NUNC plates, Falcon plates, and 12-well plates.  The NUNC plates were used for general 
growth of stem cells.  The Falcon plates were used for retinoic acid-induced neuronal 
differentiation.  The 12-well plates were used for siRNA treatments.  The medium used 
for maintaining cells was Dulbecco’s Modified Eagle’s Medium (DMEM) containing 
10% fetal bovine serum and 1% antibiotic.  Phosphate Buffer Saline was used to wash the 
cells and trypsin was used to detach the cells.  The cells were grown and stored in a 37°C 
incubator. 
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2.6.1 Unfreezing the Stock 
The stock was frozen in 1 ml of Freezing Medium which is toxic to the cells.  In 
order to prevent cell death, the stock is only partially thawed.  When the stock was 
partially thawed, it was dumped into a 15 ml conical tube containing 10 ml DMEM.  The 
conical tube was then inverted until everything was mixed.  The cells were then 
centrifuged for five minutes.  After five minutes, the cells form a pellet at the bottom of 
the conical tube.  The excess medium was then removed and the pellet was resuspended 
in 2ml of DMEM.  The cells were then plated in 10 ml DMEM in a NUNC plate. 
2.6.2 Maintaining Growth 
The protocol for maintaining growth is pretty consistent among cell culture labs.  
Once the cells are plated in a NUNC plate they were incubated at 37°C for two days.  
After the two day incubation period, the DMEM was removed and 5 ml of PBS was 
added to wash the cells.  The PBS was gently swirled and then removed.  Then, 1 ml of 
trypsin was added to the plate to detach the cells from the bottom of the plate.  Once the 
trypsin was added, the plate was placed in the 37°C incubator for three minutes.  The 
plate was gently hit to detach the cells from the plate.  In order to stop the trypsinization, 
9 ml of DMEM was added to the plate.  In order to break up the cells, it was necessary to 
pipette up and down about ten times.  A new plate was labeled and 10 ml of DMEM was 
placed in the plate.  Only 0.5 ml of cells were placed in 10 ml of DMEM leaving us with 
a 1:20 dilution.  The cells were then incubated for two days at 37°C. 
2.6.3 Neuronal Differentiation 
Retinoic acid (RA) treatment induces P19 stem cells to differentiate into neurons.  
The RA treated cells were plated in Falcon plates, where the cells did not adhere to the 
bottom of the plate.  The cells were still incubated for 2 days at 37°C. 
After stopping trypsinization of the cells, 1.5 – 3 ml of cells were plated in a 
Falcon plate containing 10 ml DMEM and 3 µl RA/ 10 ml medium.  The plate was then 
stored at 37°C, this is neuronal differentiation Day 1 (D1).  Cells form aggregates in 
suspension. 
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After two days, the medium was changed by removing all the media from the 
plate and transferring it to a 15 ml conical tube.  The tube was left to sit for five minutes 
to allow the cells to settle to the bottom of the tube.  During this time, 10 ml DMEM and 
3 µl RA were mixed in a new tube.  The medium was then removed and the fresh 
DMEM/RA mixture was used to resuspend the cells.  The total volume was transferred to 
a new Falcon plate and incubated for another two days at 37°C.   
On D5, RA treatment is complete.  The total volume from the plate is removed 
and put into a 15 ml conical tube and allowed to sit for five minutes so the cells will settle 
at the bottom.  The medium was removed from the tube and washed with 5 ml PBS, 
dispersed by flicking tube.  After washing, the PBS was removed and 3 ml of trypsin was 
added and dispersed by flicking the tube.  
The tube was then incubated for five 
minutes at 37°C.  After five minutes, the 
trypsin was removed, as much as possible, 
and 2 ml of medium was added.  By 
pipetting up and down about ten times to be 
sure the cells were completely dispersed.  1 
ml of cells was plated in 10 ml DMEM in 
NUNC a plate.   
On D7, Ara-C treatment was started.  
Ara-C incorporates into the DNA in dividing cells and thus kills any cells that divide 
(such as glia and fibroblasts as well as undifferentiated stem cells).  Therefore, Ara-C 
kills any stem cells that were not differentiated into neurons.  For 1 ml of DMEM, 1 µl of 
Ara-C is needed.  The DMEM present in the plate was removed and 10 ml DMEM plus 
10 µl Ara-C were then added gently to the plate.  The cells were incubated for two days 
at 37°C. 
Neuron 
Figure 6:  D6 retinoic acid treatment 
2.6.4 siRNA Treatment 
siRNA treatment allows for a knockdown of a specific gene of interest.  As a trial, 
we tested knockdowns in mitogen activated protein kinase 1 (MAPK1) and Jarid1c as the 
gene of interest.  Jarid1c mutations have been found to have a part in both X-linked 
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mental retardation as well as aggression.  MAPK1-siRNA is a positive control sold by 
Qiagen. 
Shortly before transfection occurred, 100 µl of cells were seeded in each well of a 
12-well plate in 1 ml DMEM.  The plate was then incubated under normal growth 
conditions (37°C).  Then, 100 µl of DMEM without FBS was mixed with 3 µl of 2 µM 
siRNA and 6 µl HiPerfect Transfection Reagent (Qiagen) by vortexing.  The mixture was 
then incubated at room temperature for 5-10 minutes to allow a complex to form.  The 
siRNA was specific for one of three genes, MAPK1, Jarid1c, or a negative control.  The 
complex that formed was added into the wells containing newly seeded cells in a drop-
wise fashion, and after gently rocking the plate to ensure uniform distribution; the plate 
was placed back into the 37°C incubator for two days. 
After two days, a photo was taken of each well and then they were harvested.  The 
DMEM was removed and each well was washed with 1 ml of PBS.  The PBS was 
removed and 500 µl of RLT + 5 µl βME were added to each well.  It was allowed to sit 
for two minutes and then the plate was struck to disrupt the cells.  Everything was 
completely removed from each well and placed in a labeled microcentrifuge tube and 
stored at -20°C.  These cells were later used to extract RNA from. 
2.6.5 Harvesting Cells 
Harvesting the cells allows us to freeze for later use, most likely an RNA 
extraction. 
The DMEM was removed from the plate.  The cells were washed with 5 ml of 
PBS, and the PBS was gently removed.  The cells were trypsinized using 1 ml of trypsin, 
incubating the plate for two minutes at 37°C.  The trypsinization process was stopped 
with 2 ml of DMEM.  As long as the cell types are the same, they can be combined into 
one tube and then centrifuged for five minutes.  Then the DMEM + trypsin was removed 
from the cells and washed with 5 ml PBS by disrupting the pellet.  Centrifuge again for 
five minutes.  Removing as much of the supernatant as possible, the cell were then ready 
to be stored at -80°C. 
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2.6.6 Freezing Cells 
Freezing cells is helpful if you are going to be away from the cells for more than a 
few days.  The DMEM was removed from the plate.  The cells were washed with 5 ml of 
PBS and then the PBS was gently removed.  The cells were trypsinized using 1 ml 
trypsin, incubating the plate for three minutes.  The cells were dispersed by hitting the 
plate.  The trypsinization was stopped by adding 5 ml DMEM.  Then, the tube was 
centrifuged for five minutes.  Without disturbing the pellet, as much medium as possible 
was removed.  The pellet was then resuspended in freezing medium containing DMSO 
and 1 ml of the mixture was added to each cryotube.  The cells were then stored at -80°C. 
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3 Results 
3.1 SuperArray Results 
SuperArray analyses of 84 neurotransmitter receptor genes were performed on 4 
biologically independent samples (2 per sex).  Some genes were found to have higher 
expression in females such as Sstr3 and Gabrb3, and some higher in males, such as 
Anxa9.  Gabrb3 is a receptor subunit for the neurotransmitter GABA, a major inhibitory 
transmitter of the nervous system.  Mutations in this gene may be associated with the 
pathogenesis of Angelman syndrome, Prader-Willi syndrome, and autism. (National 
Center for Biotechnology Information, Gabrb3).  Sstr3 is somatosation receptor 3.  It acts 
to inhibit the release of hormones and other secretory proteins at many different sites.  It 
is expressed in the highest levels in brain and pancreatic islets. (National Center for 
Biotechnology Information, Sstr3).  Anxa9 (annexin A9) encodes a divergent member of 
the annexin protein family having a structural analysis that suggests the conserved 
putative ion channel that is formed by the tetrad core. (National Center for 
Biotechnology, Anxa9). 
In addition, some genes were found to be more actively transcribed in the 
amygdala, Gad1 and Gabra1, while some were expressed at much lower levels, Npy6r 
and Tacr2.  Gad1, glutatmate decarboxylase 1, is the rate-limiting enzyme in GABA 
synthesis and is identified as a major autoantigen in insulin-dependant diabetes and 
deficiency in this enzyme has been shown to lead to seizures (National Center for 
Biotechnology Information, Gad1).  Like Gabrb3, Gabra1 is a receptor subunit for the 
major inhibitory neurotransmitter GABA in the mammalian brain.  At least 16 distinct 
subunits of GABA-A receptors have been identified (National Center for Biotechnology 
Information, Gabra1).  Tacr2, tachykinin receptor 2, belongs to a family of genes that 
functions as receptors belonging to this family are characterized with G proteins and 7 
hydrophobic transmembrane regions. 
Our results such as the female-bias in expression of Sstr3 are consistent with 
previous findings including the up-regulatory effect of estrogens on Sstr3 expression.   
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3.2 Individual Gene Results 
Gabrb3 and Sstr3 were verified to be expressed more highly in the female 
amygdala than in males (*: p < .05 in both cases).  Another GABA receptor gene, 
Gabra5, showed no sex difference in expression therefore the sex difference appears to 
be specific for certain GABA receptor genes but not others.  No sex difference was found 
in expression of Anxa9 when 6 male and 6 female amygdala samples were tested, in spite 
of the SuperArray result.  
 
Figure 7:  Graph A compares expression of Gabrb3 between males and females which shows that 
females had a higher level of Gabrb3 mRNA in the amygdala than males.  Graph B shows that the 
female bias in expression is consistent with up-regulatory effects of estrogen on Sstr3 expression. 
Figure 7A shows the difference in Gabrb3 expression.  As it can be seen, the expression 
of Gabrb3 shows a significant difference, * = p < 0.5 with a higher expression in females.  
Figure 7B shows the difference in Sstr3 expression, and it also shows a significant 
difference, * = p < 0.5. 
3.3 siRNA Results 
As a test for methodology, 
siRNA specific for Mapk1 was 
injected into the dorsal 
hippocampus and quantitative real 
time PCR was performed 48 hr 
later.  Mapk1 was found to be specifically 
silenced as can be seen in Figure 8.   
Figure 8: Expression of Mapk1 siRNA implying that 
Mapk1-siRNA treated brains the expression of Mapk1 
was silenced. 
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4 Discussion 
Gabrb3, a gene which is implicated in autism in humans, was found to be expressed 
more highly in female amygdala than in males in mice.  It is unclear whether a similar 
sex difference will be identified in humans and whether such a sex difference contributes 
to the difference in vulnerability in autism.  If Gabrb3 is also expressed more highly in 
human females than males, we can make the connection that Gabrb3 has some affect on 
blocking autism in humans.  In the future we will compare Gabrb3 expression in BTBR 
mice.  BTBR mice are so called “autistic mice”.  These mice exhibit autistic physical 
behaviors, such as anti-social behavior, and not playing as much with other mice.  In 
addition, using siRNA brain region-specific gene silencing, we will delineate in the future 
whether Gabrb3 gene plays a role in sex differences in behavior such as mouse social 
play behavior.  Our goal for the future would be to inject Gabrb3 siRNA into the 
amygdala. 
Sstr3, a gene encoding somatosatin receptor subtype, was also found to be expressed 
higher in females than in males.  This sex difference has been previously shown to be due 
to the effect of estrogen.  Based on this information we cannot deduce what effect Sstr3 
has regarding autism.  The next step would be to do comparative analysis between male 
and female mice, as well as between males with no testes and females with testosterone. 
 Based on our findings, we cannot make any definitive conclusions on what genes 
affect human autism.  However, this evidence will hopefully lead us in the correct 
direction to isolate the genes responsible for autism in humans. 
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6 Appendices 
6.1 Appendix A:  Gene Table of Mouse Neurotransmitter Receptors 
and Regulators  
 
Position Symbol Description 
A01 Ache Acetylcholinesterase 
A02 Anxa9 Annexin A9 
A03 Brs3 Bombesin-like receptor 3 
A04 Cckar Cholecystokinin A receptor 
A05 Cckbr Cholecystokinin B receptor 
A06 Chat Choline acetyltransferase 
A07 Chrm1 Cholinergic receptor, muscarinic 1, CNS 
A08 Chrm2 Cholinergic receptor, muscarinic 2, cardiac 
A09 Chrm3 Cholinergic receptor, muscarinic 3, cardiac 
A10 Chrm4 Cholinergic receptor, muscarinic 4 
A11 Chrm5 Cholinergic receptor, muscarinic 5 
A12 Chrna1 Cholinergic receptor, nicotinic, alpha polypeptide 1 (muscle) 
B01 Chrna2 Cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal) 
B02 Chrna3 Cholinergic receptor, nicotinic, alpha polypeptide 3 
B03 Chrna4 Cholinergic receptor, nicotinic, alpha polypeptide 4 
B04 Chrna5 Cholinergic receptor, nicotinic, alpha polypeptide 5 
B05 Chrna6 Cholinergic receptor, nicotinic, alpha polypeptide 6 
B06 Chrna7 Cholinergic receptor, nicotinic, alpha polypeptide 7 
B07 Chrnb1 Cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) 
B08 Chrnb2 Cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) 
B09 Chrnb3 Cholinergic receptor, nicotinic, beta polypeptide 3 
B10 Chrnb4 Cholinergic receptor, nicotinic, beta polypeptide 4 
B11 Chrnd Cholinergic receptor, nicotinic, delta polypeptide 
B12 Chrne Cholinergic receptor, nicotinic, epsilon polypeptide 
C01 Chrng Cholinergic receptor, nicotinic, gamma polypeptide 
C02 Comt Catechol-O-methyltransferase 
C03 Drd1a Dopamine receptor D1A 
C04 Drd2 Dopamine receptor 2 
C05 Drd3 Dopamine receptor 3 
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C06 Drd4 Dopamine receptor 4 
C07 Drd5 Dopamine receptor 5 
C08 Gabra1 Gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 1 
C09 Gabra2 Gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 2 
C10 Gabra3 Gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 3 
C11 Gabra4 Gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 4 
C12 Gabra5 Gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 5 
D01 Gabra6 Gamma-aminobutyric acid (GABA-A) receptor, subunit alpha 6 
D02 Gabrb2 Gamma-aminobutyric acid (GABA-A) receptor, subunit beta 2 
D03 Gabrb3 Gamma-aminobutyric acid (GABA-A) receptor, subunit beta 3 
D04 Gabrd Gamma-aminobutyric acid (GABA-A) receptor, subunit delta 
D05 Gabrg1 Gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 1
D06 Gabrg2 Gamma-aminobutyric acid (GABA-A) receptor, subunit gamma 2
D07 Gabrp Gamma-aminobutyric acid (GABA-A) receptor, pi 
D08 Gabrq Gamma-aminobutyric acid (GABA-A) receptor, subunit theta 
D09 Gabrr1 Gamma-aminobutyric acid (GABA-C) receptor, subunit rho 1 
D10 Gabrr2 Gamma-aminobutyric acid (GABA-C) receptor, subunit rho 2 
D11 Gad1 Glutamic acid decarboxylase 1 
D12 Galr1 Galanin receptor 1 
E01 Galr2 Galanin receptor 2 
E02 Galr3 Galanin receptor 3 
E03 Glra1 Glycine receptor, alpha 1 subunit 
E04 Glra2 Glycine receptor, alpha 2 subunit 
E05 Glra3 Glycine receptor, alpha 3 subunit 
E06 Glra4 Glycine receptor, alpha 4 subunit 
E07 Glrb Glycine receptor, beta subunit 
E08 Gpr103 G protein-coupled receptor 103 
E09 Npffr1 Neuropeptide FF receptor 1 
E10 Prokr1 Prokineticin receptor 1 
E11 Prokr2 Prokineticin receptor 2 
E12 Npffr2 Neuropeptide FF receptor 2 
F01 Gpr83 G protein-coupled receptor 83 
F02 Grpr Gastrin releasing peptide receptor 
F03 Htr3a 5-hydroxytryptamine (serotonin) receptor 3A 
F04 Maoa Monoamine oxidase A 
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F05 Mc2r Melanocortin 2 receptor 
F06 Nmur1 Neuromedin U receptor 1 
F07 Nmur2 Neuromedin U receptor 2 
F08 Npy1r Neuropeptide Y receptor Y1 
F09 Npy2r Neuropeptide Y receptor Y2 
F10 Npy5r Neuropeptide Y receptor Y5 
F11 Npy6r Neuropeptide Y receptor Y6 
F12 Ntsr1 Neurotensin receptor 1 
G01 Pgr15l G protein-coupled receptor 15-like 
G02 Ppyr1 Pancreatic polypeptide receptor 1 
G03 Prlhr Prolactin releasing hormone receptor 
G04 Slc5a7 Solute carrier family 5 (choline transporter), member 7 
G05 Sstr1 Somatostatin receptor 1 
G06 Sstr2 Somatostatin receptor 2 
G07 Sstr3 Somatostatin receptor 3 
G08 Sstr4 Somatostatin receptor 4 
G09 Sstr5 Somatostatin receptor 5 
G10 Tacr1 Tachykinin receptor 1 
G11 Tacr2 Tachykinin receptor 2 
G12 Tacr3 Tachykinin receptor 3 
H01 Gusb Glucuronidase, beta 
H02 Hprt1 Hypoxanthine guanine phosphoribosyl transferase 1 
H03 Hsp90ab1 Heat shock protein 90kDa alpha (cytosolic), class B member 1 
H04 Gapdh Glyceraldehyde-3-phosphate dehydrogenase 
H05 Actb Actin, beta, cytoplasmic 
H06 MGDC Mouse Genomic DNA Contamination 
H07 RTC Reverse Transcription Control 
H08 RTC Reverse Transcription Control 
H09 RTC Reverse Transcription Control 
H10 PPC Positive PCR Control 
H11 PPC Positive PCR Control 
H12 PPC Positive PCR Control 
 
